Improved Outcomes in Critically Ill Dementia

IN THIS ISSUE: Colloquium | CommitteesVirtual Journal Club | What’s on the Web | A&E Abstracts

Improved Outcomes in Critically Ill Dementia

Next ACLP Virtual Journal Club session

The next ACLP Virtual Journal Club session on Zoom is on the article:

Donepezil treatment is associated with improved outcomes in critically ill dementia
Wednesday, June 11, 12:30-1:00 PM EST

This session will be presented by Ori Lieberman, MD, and moderated by Badr Ratnakaran, MD.

Ori Lieberman, MD
Ori Lieberman, MD

Dr. Lieberman is a neurology resident at University of California, San Francisco, and chief resident in neurology at Zuckerberg San Francisco General Hospital. His research focuses on the interaction between systemic organ dysfunction and brain injury during critical illness. He will be a neurocritical care fellow at UCSF next year.

In preparation, please read the article beforehand: Lieberman OJ, Lee S, Zabinski J. Donepezil treatment is associated with improved outcomes in critically ill dementia patients via a reduction in delirium. Alzheimers Dement. 2023 May;19(5):1742-1751. doi: 10.1002/alz.12807.

The article should be available free of charge!

ACLP Virtual Journal Club sessions are held every two months and focus on articles from the American Board of Psychiatry and Neurology’s Article-Based Continuing Certification pathway for C-L Psychiatry.

 

 

« All 2025 ACLP News« June 2025 ACLP News